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OBJECTIVES We sought to determine whether or not inhaled nitric oxide (NO) could improve
hemodynamic function in patients with right ventricular myocardial infarction (RVMI) and
cardiogenic shock (CS).
BACKGROUND Inhaled NO is a selective pulmonary vasodilator that can decrease right ventricular afterload.
METHODS Thirteen patients (7 males and 6 females, age 65  3 years) presenting with electrocardio-
graphic, echocardiographic, and hemodynamic evidence of acute inferior myocardial infarc-
tion associated with RVMI and CS were studied. After administration of supplemental
oxygen (inspired oxygen fraction [FiO2]  1.0), hemodynamic measurements were recorded
before, during inhalation of NO (80 ppm at FiO2  0.90) for 10 min, and 10 min after NO
inhalation was discontinued (FiO2  1.0).
RESULTS Breathing NO decreased the mean right atrial pressure by 12  3%, mean pulmonary arterial
pressure by 13  2%, and pulmonary vascular resistance by 36  8% (all p  0.05). Nitric
oxide inhalation increased the cardiac index by 24  11% and the stroke volume index by 23
 12% (p  0.05). The NO administration did not change systemic arterial or pulmonary
capillary wedge pressures. Contrast echocardiography identified three patients with a patent
foramen ovale and right-to-left shunt flow while breathing at FiO2  1.0. Breathing NO
decreased shunt flow by 56  5% (p  0.05) and was associated with markedly improved
systemic oxygen saturation.
CONCLUSIONS Nitric oxide inhalation results in acute hemodynamic improvement when administered to
patients with RVMI and CS. (J Am Coll Cardiol 2004;44:793–8) © 2004 by the American
College of Cardiology Foundationt
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(ight ventricular myocardial infarction (RVMI) is observed in
p to 50% of patients with acute left ventricular (LV) inferior-
osterior wall infarction (1), many of whom manifest signifi-
ant hemodynamic abnormalities, including cardiogenic shock
CS) characterized by increased venous pressure, a low cardiac
utput, and systemic hypotension (2,3). The current treatment
f RVMI patients includes optimization of right ventricular
RV) and LV preload with intravenous fluids, coronary reper-
usion, maintenance of atrioventricular synchrony, administra-
ion of inotropic agents, and intra-aortic balloon pump coun-
erpulsation (2,4–6). Many RVMI patients with impaired
ardiac function improve with these therapies, particularly after
arly percutaneous coronary intervention (PCI) (4). Dobut-
mine and nitrovasodilators have been infused to improve the
ardiac index (CI) of patients with CS complicating RVMI
6), but their utility is limited by arrhythmias, systemic vaso-
ilation, and hypotension. Furthermore, RVMI patients with a
atent foramen ovale may develop hypoxemia as a result of
ight-to-left shunting (7) that is resistant to conventional
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herapeutic use of inhaled nitric oxide and may receive royalties. Dr. Bloch has a
ponsored research agreement with iNO Therapeutics.
Manuscript received February 4, 2004; revised manuscript received April 30, 2004,
dccepted May 4, 2004.herapy including supplemental oxygen. Overall, RVMI pa-
ients with CS have in-hospital mortality similar to that of LV
yocardial infarction (MI) patients with CS (4,8).
Afterload reduction therapy for the failing RV with a
elective pulmonary vasodilator might be expected to lead to
mproved cardiac performance without producing systemic
asodilation and hypotension (9,10). Pulmonary vasodilation
an occur when inhaled nitric oxide (NO) diffuses to smooth
uscle cells in lung arterioles and activates soluble guanylate
yclase to generate cyclic 3=, 5=-monophosphate (11,12). This
ntracellular messenger leads to a reduction in the intracellular
oncentration of calcium and inhibition of myosin light chain
inase, producing smooth muscle cell relaxation and vasodila-
ion (13). The vasodilator effects of inhaled NO are restricted
o the pulmonary circulation, as NO is readily bound to
emoglobin in circulating erythrocytes and inactivated (14).
reathing NO has been shown to decrease pulmonary vascular
one in adults and children with pulmonary hypertension of
iverse etiology without causing systemic vasodilation, includ-
ng patients with congenital heart disease (15), primary pul-
onary hypertension (9), and pulmonary hypertension second-
ry to a variety of etiologies (10). Inhaled NO has also been
hown to improve oxygenation and reduce the need for
xtracorporeal membrane oxygenation in newborns with per-
istent pulmonary hypertension and hypoxic respiratory failure
16,17). Furthermore, inhaled NO has been observed to
ecrease RV afterload in a porcine model of RVMI (18).
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NO in Right Ventricular Infarction August 18, 2004:793–8The objective of this study was to assess whether or not
O inhalation could improve cardiac performance in pa-
ients with RVMI and CS.
ETHODS
his protocol was approved by the Massachusetts General
ospital Subcommittee on Human Studies.
tudy population. Patients with acute inferior MI (defined
s an episode of chest pain lasting30 min and electrocardio-
raphic evidence of 1 mm ST elevation in inferior leads
ithin the past 7 days) presenting to the Massachusetts
eneral Hospital were prospectively screened for electrocar-
iographic (1 mm ST-segment elevation on right precordial
eads V3R or V4R) or echocardiographic (RV dilation and free
all akinesis or dyskinesis) evidence of RVMI.
Informed consent was obtained from 19 patients meeting
hese criteria. Diagnostic coronary angiography was per-
ormed, and PCI was carried out at the discretion of the
Abbreviations and Acronyms
CI  cardiac index
CS  cardiogenic shock
FiO2  inspired oxygen fraction
HR  heart rate
LV  left ventricle/ventricular
MI  myocardial infarction
NO  nitric oxide
PA  pulmonary artery/arterial
PCI  percutaneous coronary intervention
PCWP pulmonary capillary wedge pressure
PVR  pulmonary vascular resistance
RA  right atrium/atrial
RV  right ventricle/ventricular
RVMI  right ventricular myocardial infarction
SAP  systemic arterial pressure
TIMI  Thrombolysis In Myocardial Infarction
able 1. Patient Characteristics at the Time of Study Enrollment
atient
No.
Age
(yrs) Gender
PCI
Success*
Time to
Enrollment‡
(h) IABP
1 66 M N/A 30 
2 74 F No 5 
3 65 F Yes† 96 
4 62 M N/A 48 
5 49 M Yes 12 
6 66 M Yes 5 
7 48 M Yes† 44 
8 62 F No 68 
9 48 M Yes 16 
10 73 F Yes† 96 
11 84 F Yes 72 
12 65 F Yes† 120 
13 86 M Yes† 20 
Mean 65  3 49  11
Successful percutaneous coronary intervention (†indicates patients in whom PCI did
tudy enrollment. §Norepinephrine or phenylephrine administration. Oxygen delive
FiO2  inspired oxygen fraction; IABP  intraaortic balloon counterpulsation; N
rterial oxygen saturation as measured by pulse oximetry.ttending cardiologist. The success of PCI was assessed
sing both the Thrombolysis In Myocardial Infarction
TIMI) study criteria for successful reperfusion (50%
esidual stenosis and restoration of TIMI flow grade 3 in the
istal right coronary artery [19]) and the more stringent
riteria of Bowers et al. (4) requiring complete reperfusion
f the right coronary artery and all RV marginal branches
1 mm in diameter. Transthoracic echocardiography and
ight heart catheterization were then performed. Patients
eceived intravenous normal saline if their pulmonary cap-
llary wedge pressure (PCWP) was 15 mm Hg. Patients
ere then included for further study if their right atrial (RA)
ressure was10 mm Hg, their PCWP was no5 mm Hg
igher than the RA pressure, and their CI was 2.5
/min/m2. Patients were excluded from study if they had
evere pulmonary edema (PCWP 25 mm Hg; n  4),
echanical complications of MI requiring urgent surgical
orrection (n  0), severe mitral or aortic valvular disease (n
1), persistent hemodynamically significant tachyarrhyth-
ias (n  1), or a history of clinically significant pulmonary
isease (n  0). Thirteen patients underwent further study.
tudy procedure. To minimize hypoxic pulmonary vaso-
onstriction and to standardize the concentration of oxygen
dministered to patients participating in the study, the
nspired oxygen fraction (FiO2) was increased to 1.0 in
atients who were intubated with an endotracheal tube (n
0), and 100% oxygen was administered via a tight-fitting
ace mask to patients who were not intubated (n 3) (Table
). After 10 min, the following parameters were recorded:
A, pulmonary arterial (PA), PCWP, and mean systemic
rterial pressure (SAP), as well as heart rate (HR). Cardiac
utput was determined by the Fick oxygen technique. The
I, stroke volume index, pulmonary vascular resistance
PVR), and systemic vascular resistance were calculated
sing standard formulas. Patients then breathed 80 ppm
O at FiO2  0.90 for 10 min, and hemodynamic
asopressors§ Dobutamine
Mechanical
Ventilation FiO2
SaO2
(%)
   1.0 82
   0.8 92
   0.4 100
   0.8 83
   1.0 71
   0.4 97
   0.6 98
   0.5 95
   0.7 88
   0.4 100
   0.4 97
   0.9 95
   0.3 100
0.6  0.1 92  2
sult in restoration of right ventricular perfusion). ‡Time from onset of symptoms to
face mask or nasal prongs. Values expressed as mean  SEM.
PCI not attempted; PCI  percutaneous coronary intervention; SaO2  systemicV
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August 18, 2004:793–8 NO in Right Ventricular Infarctioneasurements were repeated. Nitric oxide administration
as stopped, patients resumed breathing at FiO2 1.0, and
third set of hemodynamic measurements was recorded 10
in later. We chose an inhaled concentration of 80 ppm
O because this dose has been reported to provide a greater
ulmonary vasodilator response than lower doses (20).
oreover, breathing 80 ppm NO for 10 min is not
ssociated with adverse effects such as methemoglobinemia
n adults (20).
In patients with a systemic oxygen saturation95% despite
reathing at FiO2  1.0, contrast echocardiography was used
o identify the presence of right-to-left shunting via a patent
oramen ovale. The magnitude of right-to-left shunt flow was
ssessed by oximetry (21). The pulmonary venous oxygen
ontent was calculated using the alveolar gas equation (22), as
here were no patients with significant pulmonary disease, and
ll patients were breathing at FiO2  1.0.
O administration. Nitric oxide gas was supplied in tanks
ontaining 800 ppm NO in N2 (INO Therapeutics Inc.,
linton, New Jersey) and was administered using an INO-
ent (Datex-Ohmeda Inc., Andover, Massachusetts) to
upply NO at a concentration of 80 ppm to the inspiratory
imb of a ventilator circuit or a tight-fitting mask. A flow
ate of 30 l/min of NO gas mixed with oxygen was
aintained to meet the inspiratory flow demands of the
atient and to minimize the transit time of the inspired gas
nd hence the formation of higher nitrogen oxides. Nitric
xide, NO2, and FiO2 were monitored continuously; in all
ases, NO2 was 2 ppm.
tatistical analysis. Continuous variables are expressed as
ean standard error, with median values provided where the
ata were not normally distributed as assessed by the Wilk-
hapiro test. Hemodynamic and gas exchange alterations in
esponse to NO breathing and its discontinuation were ana-
yzed using repeated measures analysis of variance followed by
able 2. Hemodynamic Parameters at the Time of Study Enrollm
atient
No.
RAP
(mm Hg)
PAP
(mm Hg)
PCWP
(mm Hg)
SAP
(mm Hg)
1 20 26 12 80
2 25 28 20 68
3 18 25 18 78
4 27 31 24 78
5 24 33 20 59
6 18 20 14 75
7 20 34 23 90
8 17 27 19 78
9 22 28 20 62
10 13 25 15 50
11 16 31 18 59
12 18 24 19 80
13 21 26 19 74
Mean 20  1 28  1 19  1 72  3
ean values expressed as mean  SEM.
CI  cardiac index; LVEF  left ventricular ejection fraction; PAP  mean p
ulmonary vascular resistance; RAP  mean right atrial pressure; SAP  mean systhe Neuman-Keuls procedure, when appropriate. Data sam- cles were assessed for equal variance before analysis of variance.
value of p  0.05 was considered significant.
ESULTS
aseline characteristics. The characteristics of the study
opulation are summarized in Table 1. There were seven men
nd six women, age 65  3 years. The right coronary artery
as dominant in all patients. Two patients (#9 and #11)
eceived thrombolytic therapy before coronary angiography.
wo patients (#6 and #11) had a 95% proximal stenosis of
he right coronary artery with TIMI grade 2 distal flow, and
he nine remaining patients had total occlusion of the proximal
ight coronary artery. The PCI was successful, as assessed by
he TIMI criteria, in 9 of the 11 patients in whom it was
ttempted. However, PCI resulted in complete reperfusion of
he right coronary artery and all RV marginal branches1 mm
n only four patients. The elapsed time from the onset of
ymptoms to the PCI procedure was 21 10 h (median: 8 h).
n two patients (#1 and #4), PCI was not attempted.
At the time of enrollment in the study, 9 patients
equired intra-aortic balloon pump counterpulsation, 10
atients required treatment with norepinephrine or phenyl-
phrine, and 6 patients required treatment with dobut-
mine. Ten patients required mechanical ventilation via an
ndotracheal tube, including a positive end-expiratory pres-
ure 5 cm H2O. Five patients (#2, #3, #5, #8, and #10)
ad bradyarrhythmias requiring ventricular pacing. The
lapsed time from the onset of chest pain to initiation of the
O inhalation study was 49  11 h.
The hemodynamic parameters of the patients at the time
f enrollment are presented in Table 2. The mean RA, PA,
nd PCWPs were elevated, as were the PVR and systemic
ascular resistance. The mean PA systolic pressure was 36
mm Hg. The CI was low (1.7  0.1 l/min/m2). All
atients had RV dilation and systolic dysfunction by echo-
CI
/min/m2)
PVR
(dynes·s·cm5)
SVR
(dynes·s·cm5) LVEF
1.1 599 2567 0.40
1.9 216 1161 0.30
1.4 224 1920 0.30
1.3 190 1383 0.70
1.2 347 933 0.35
1.3 169 1609 0.45
2.5 152 966 0.70
2.0 211 1605 0.31
1.6 221 1103 0.30
2.3 179 663 0.45
2.0 236 782 0.45
0.8 267 3307 0.42
2.1 147 1116 0.35
.7  0.1 243  34 1,470  210 0.42  0.04
ary arterial pressure; PCWP  mean pulmonary capillary wedge pressure; PVR 
rterial pressure; SVR  systemic vascular resistance.ent
(l
1
ulmonardiography. The LV ejection fraction was 0.42  0.04.
H
t
s


8
2
0
v
t
v
a
5
I
s
d
e
l
f
L
r
a
a
o
t
m
o
D
W
t
b
R
i
F
i
o
i
t
F
d
r
r  0.
796 Inglessis et al. JACC Vol. 44, No. 4, 2004
NO in Right Ventricular Infarction August 18, 2004:793–8emodynamic effects of inhaled NO administra-
ion. The effects of breathing 80 ppm NO for 10 min are
hown in Figure 1. When compared with breathing at FiO2
1.0, the addition of NO decreased the RA pressure by 12
3%, mean PA pressure by 13  2%, and PVR by 36 
% (all p  0.05). The NO administration increased CI by
4  11% and stroke volume index by 23  12% (both p 
.05) but did not change SAP and PCWP, systemic
ascular resistance, or HR. Ten minutes after discontinua-
igure 2. Right-to-left shunt flow and systemic arterial oxygen saturation
n three right ventricular myocardial infarction patients before (Pre-nitric
xide [NO]), during (NO), and 10 min after the discontinuation of NO
nhalation (Post-NO). Diamonds  Patient #1; squares  Patient #5;
igure 1. Hemodynamic parameters in right ventricular myocardial infarct
iscontinuation of NO inhalation (Post-NO). RAP  mean right atrial p
esistance; CI  cardiac index; PCWP  mean pulmonary capillary wed
esistance; HR  heart rate. *p  0.05 versus Pre-NO and Post-NO; †pariangles  Patient #4.ion of NO, the RA pressure, PVR, and CI had returned to
alues similar to those measured immediately before NO
dministration. The mean PA pressure, however, remained
 2% lower than before NO administration (p  0.05).
nhaled NO was well tolerated in all patients without any
ide effects.
Four patients had a systemic oxygen saturation 95%
espite breathing at FiO2  1.0 and underwent contrast
chocardiography. In three patients (#1, #4, and #5), right-to-
eft shunting of bubble contrast medium through a patent
oramen ovale was observed, and a shunt flow of 0.67  0.08
/min was measured by oximetry. Inhaled NO decreased
ight-to-left shunting by 56  5% (p  0.05) associated with
n increase of systemic arterial oxygen saturation to 95% in
ll three patients (Fig. 2). In one patient (#2) with a systemic
xygen saturation 95%, transthoracic echocardiography was
echnically limited, precluding identification of a patent fora-
en ovale. Nonetheless, breathing NO increased the systemic
xygen saturation in this patient.
ISCUSSION
e observed that short-term administration of inhaled NO
o a group of patients with RVMI and CS resulted in
eneficial hemodynamic effects, as reflected by a decrease of
A and PA pressures and an increase of CI. Nitric oxide
nhalation produced pulmonary vasodilation but did not
tients before (Pre-nitric oxide [NO]), during (NO), and 10 min after the
e; PAP  mean pulmonary arterial pressure; PVR  pulmonary vascular
ssure; SAP  mean systemic arterial pressure; SVR  systemic vascular
05 versus Pre-NO.ion pa
ressur
ge prelter SAP and PCWP or the HR. In three patients with
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August 18, 2004:793–8 NO in Right Ventricular Infarctionignificant right-to-left shunting through a patent foramen
vale that was refractory to oxygen administration, NO
nhalation reduced shunt flow and improved systemic oxy-
enation. Short-term administration of inhaled NO was
ell tolerated by all patients without significant side effects.
All of the patients with RVMI and CS that were studied
ad an abnormally elevated PVR. The elevation in PA pressure
bserved in our patients was similar to that reported by Jacobs
t al. (8) in their registry of patients with RVMI and CS. The
ncreased pulmonary vascular tone in our patients with RVMI
nd CS is likely multifactorial in etiology. A low cardiac output
esults in a decreased mixed venous blood oxygen content,
hich enhances PA vasoconstriction (23). The intravenous
nfusion of alpha-adrenergic vasoconstrictors can contribute to
ulmonary vasoconstriction, as has been reported in animal
odels (24,25). Mechanical ventilation with positive end-
xpiratory pressure 5 cm H2O, as was used in five of the
atients in this study, can increase the PVR through compres-
ion of the pulmonary vasculature (26). Finally, interstitial
ulmonary edema, which may have occurred in some of our
atients with an elevated PCWP, can also cause pulmonary
onstriction (27). Our observations of a selective pulmonary
asodilator effect of breathing NO are consistent with previous
tudies of patients with pulmonary hypertension secondary to a
ariety of etiologies in which pulmonary vasomotor tone is
ncreased (9,10,15), suggesting that the increased PVR in our
atients is related to an increase in pre-capillary vasomotor tone
ather than compressive effects on pulmonary capillaries.
The increase of CI and reduction of RA pressure ob-
erved in RVMI patients breathing NO are likely due to
elective pulmonary vasodilation, resulting in a reduction of
V afterload and subsequent improvement in RV perfor-
ance. These effects are in agreement with those reported
n two previous case reports of RVMI patients treated with
nhaled NO (28,29).
The selectivity of inhaled NO for the pulmonary circu-
ation offers a significant advantage over non-selective pul-
onary and systemic vasodilators, such as nitroprusside,
or the treatment of RVMI patients. Dell’Italia et al. (6)
eported that systemic administration of nitroprusside to
VMI patients increased CI without augmenting stroke
olume index, and was associated with decreased SAP and
CWP and an increased HR. The nitroprusside-induced
ncrease of HR suggests that nonselective vasodilation in
VMI patients can increase sympathetic tone, which may
ugment ischemia, arrhythmias, and promote infarct expan-
ion. Dell’Italia et al. (6) also reported that administration of
he beta-adrenergic agonist dobutamine to RVMI patients
ncreased CI and stroke volume index but was associated
ith arrhythmias and recurrent ischemia. In contrast, we
bserved that breathing NO for 10 min increased CI and
troke volume index without decreasing SAP or PCWP or
ncreasing the HR in our patients with RVMI and CS.
revious studies have shown that inhaled NO does not
ffect RV or LV contractility (9,30) and therefore may prove
uperior to currently available therapies for the low CI and Rystemic venous congestion seen in RVMI patients with
S, improving cardiac performance without producing
dverse myocardial effects.
In this study, PCWP did not change during NO inha-
ation by RVMI patients, as has been previously observed
uring its administration to patients with severe LV systolic
ysfunction (20,31). In patients with severe LV systolic
ysfunction, which is usually accompanied by poor diastolic
entricular compliance, breathing NO is thought to increase
ulmonary venous return, resulting in an increase in LV
lling pressure (32). The RVMI patients in this study had
rimarily RV systolic and diastolic function, and the degree
f LV dysfunction was not as severe as in those patients in
hom the PCWP has been reported to increase during NO
nhalation. Furthermore, RVMI patients have been ob-
erved to have a shift of the interventricular septum towards
he left ventricle, impairing LV diastolic compliance and
ncreasing LV filling pressure. In our patient population,
O inhalation decreased RV filling pressure, which may
ave decreased the deleterious effect of the RV on LV
ompliance, counterbalancing any effect that increased LV
lling might have had on the PCWP.
Right-to-left shunt flow through a patent foramen ovale
aused by elevation of RV filling pressure is a well-described
omplication of patients with RVMI and can produce
efractory systemic hypoxemia (7). Systemically adminis-
ered vasodilator or inotropic therapy has limited efficacy in
ecreasing shunt flow, as agents that decrease RA pressure
imultaneously reduce the left atrial pressure, leaving the
ransatrial pressure gradient unchanged. Attempts to me-
hanically close a patent foramen ovale to decrease inter-
trial shunting in RVMI patients have had variable success
33,34). In our study, we observed that 3 of 13 RVMI
atients had significant right-to-left shunting through a
atent foramen ovale despite breathing at FiO2  1.0,
hereas breathing NO consistently reduced the shunt flow
nd improved systemic oxygenation.
Our study expands upon the previous report of Bowers et
l. (4), who observed that failure to achieve early, successful
eperfusion of the RV myocardium in RVMI patients
esulted in a high incidence of refractory hypotension, CS,
nd death. In our group of RVMI patients with severe
emodynamic compromise, the majority of whom did not
btain prompt reperfusion of their RV myocardium, breath-
ng 80 ppm NO increased the CI and stroke volume index.
f this effect can be sustained, inhaled NO therapy offers the
otential to improve cardiac performance in patients who
ail to benefit from early revascularization and who remain
ritically ill despite the use of intra-aortic and/or pharma-
ologic circulatory support.
The prognosis for most RVMI patients who survive their
nitial hospitalization is excellent, even when their course is
omplicated by CS (35), and significant improvement of
ndices of RV systolic function have been measured at
ong-term follow-up (36). Bowers et al. (4) reported that in
VMI patients with unsuccessful early perfusion and he-
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NO in Right Ventricular Infarction August 18, 2004:793–8odynamic compromise who survive their initial hospital-
zation, RV systolic wall motion at one month is similar to
atients in whom early, successful RV myocardial reperfu-
ion was achieved. Further study is necessary to ascertain if
he beneficial hemodynamic effects observed with short-
erm inhaled NO in our study of RVMI patients with CS or
efractory hypoxemia can reduce early mortality, permitting
he eventual recovery of RV function.
In summary, administration of inhaled NO results in
ignificant hemodynamic improvement and a reduction of
ight-to-left shunting when administered to patients with
cute RVMI and CS.
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